Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (90)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Frenket, K.
Right arrow Articles by Chrzan, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frenket, K.
Right arrow Articles by Chrzan, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1987 Oxford University Press

research-article

Hydrogen peroxide formation and DNA base modification by tumor promoter-activated polymorphonuclear leukocytes

Krystyna Frenket 1 2 3 and Kazimierz Chrzan 1

1Department of Environmental Medicine 550 First Avenue, New York, NY 10016, USA
2Department of Pathology, New York University Medical Center 550 First Avenue, New York, NY 10016, USA

3whom reprint requests should be sent

This report shows that generation of hydrogen peroxide (H2O2) by human polymorphonuclear leukocytes (PMNs) activated wtih tumor promoters of varying potency as first and second stage promoters correlates well with activities of these promoters in vivo. Those tested were 12-O-tetradeca-noylphorbol-13-acetate (TPA), a complete promoter, 12-0-retinoylphorbol-13-acetate (RPA), a synthetic TPA derivative almost devoid of first stage activity in some strains of mice, and mezerein (Mez), a potent second stage and much weaker first stage promoter. Mez-stimulated PMNs produced up to four times less H2O2 whereas RPA-stimulated PMNs pro-duced up to 10 times less H2O2 than TPA-activated cells when used at concentrations between 0.5 and 15 nM to activate 7.5–8.5 x 10 PMNs/ml. Phorbol, a non-promoter, was totally inactive in this assay. Furthermore, the tumor pro-moter-activated PMNs caused formation of 5-hydroxymethyl-2'-deoxyuridine (HMdU) and thymidine glycol (dTG) in DNA co-incubated with those cells. The amounts of modified thy-midines formed, particularly of HMdU, correlated well with first stage tumor promoting efficacy and with the amount of H2O2 that was generated by promoter activated PMNs. In comparison with TPA, Mez-or RPA-stimulated PMNs in-duced formation of 25 or 70% less H2O2 and 30 or 75% less HMdU, respectively, under conditions favoring HMdU for-mation. Thus, formation of either H2O2 by tumor promoter-stimulated phagocytes or HMdU in DNA exposed to those activated cells may serve as a measure of potency as a first stage tumor promoter. Formation of modified bases such as HMdU in DNA might constitute the genetic change imparted by the first stage tumor promoters.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
MutagenesisHome page
A. M. Knaapen, N. Gungor, R. P. F. Schins, P. J. A. Borm, and F. J. Van Schooten
Neutrophils and respiratory tract DNA damage and mutagenesis: a review
Mutagenesis, July 1, 2006; 21(4): 225 - 236.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A.W. Boots, G.R.M.M. Haenen, and A. Bast
Oxidant metabolism in chronic obstructive pulmonary disease
Eur. Respir. J., November 2, 2003; 22(46_suppl): 14s - 27s.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Li, J. Eckard, R. Shah, C. Malluck, and K. Frenkel
Interleukin-1{alpha} Up-Regulation in Vivo by a Potent Carcinogen 7,12-Dimethylbenz(a)anthracene (DMBA) and Control of DMBA-induced Inflammatory Responses
Cancer Res., January 1, 2002; 62(2): 417 - 423.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F. Chu, N. E. Ward, and C. A. O'Brian
Potent inactivation of representative members of each PKC isozyme subfamily and PKD via S-thiolation by the tumor-promotion/progression antagonist glutathione but not by its precursor cysteine
Carcinogenesis, August 1, 2001; 22(8): 1221 - 1229.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Zhao, M. Lahiri-Chatterjee, Y. Sharma, and R. Agarwal
Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin
Carcinogenesis, April 1, 2000; 21(4): 811 - 816.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Gundimeda, Z.-H. Chen, and R. Gopalakrishna
Tamoxifen Modulates Protein Kinase C via Oxidative Stress in Estrogen Receptor-negative Breast Cancer Cells
J. Biol. Chem., June 7, 1996; 271(23): 13504 - 13514.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
F. Perera
Carcinogens and human health: Part 1
Science, December 21, 1990; 250(4988): 1644 - 1646.
[PDF]


Home page
ScienceHome page
B. Ames, R Magaw, and L. Gold
Ranking possible carcinogenic hazards
Science, April 17, 1987; 236(4799): 271 - 280.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
J. S. Liou, C.-Y. Chen, J. S. Chen, and D. V. Faller
Oncogenic Ras Mediates Apoptosis in Response to Protein Kinase C Inhibition through the Generation of Reactive Oxygen Species
J. Biol. Chem., December 8, 2000; 275(50): 39001 - 39011.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.